Investor's Business Daily on MSN1h
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up
Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a ...
Cars.com price target lowered to $21 from $25 at BTIG
BTIG analyst Marvin Fong lowered the firm’s price target on Cars.com (CARS) to $21 from $25 but keeps a Buy rating on the shares. The ...
Organogenesis price target raised to $7 from $6 at BTIG
BTIG raised the firm’s price target on Organogenesis (ORGO) to $7 from $6 and keeps a Buy rating on the shares after its Q4 results. The firm ...
Flywire (NASDAQ:FLYW) Downgraded to “Neutral” Rating by BTIG Research
Flywire (NASDAQ:FLYW – Get Free Report) was downgraded by equities research analysts at BTIG Research from a “buy” rating to ...
Stocktwits on MSN12h
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership
Novavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...
S&P 500's technical set-up suggests a short-term bounce, says BTIG's Krinsky
The S&P 500's latest sell-off took it back to its February lows of 5923, notes Jonathan Krinsky, BTIG's technical guru. That's left it in danger of breaking below the uptrend from last summer's low.
Is AvidXchange Holdings, Inc. (AVDX) the Tech Stock with Best Earnings Growth in 2025?
We recently published a list of 15 Tech Stocks with Best Earnings Growth in 2025. In this article, we are going to take a ...
Stocks could see near-term bounce, but don't be fooled: BTIG's Krinsky
The S&P 500 may be due for a short-term bounce after its pullback from last week's record highs — but don't expect it to last ...